Appointments bring broad expertise in innovation, commercialization, public policy and agriculture. CALGARY, AB – August 25, 2026 – Genome Alberta is pleased to announce the appointment of five new members to its Board of Directors. Allison Swelin, Curtis Clarke, John Wilson, Virgil Lowe and Camille Ryan were appointed following the organization’s Annual General Meeting […]
Genome Alberta Welcomes Five New Board Members Read More »
The Commercialization Gap Is Real: Rapid Infection Diagnostics Shows Why Early Investment Matters For most startups, securing enough capital to move from research to commercialization is one of the greatest challenges they will face. For Alberta-based Rapid Infection Diagnostics Inc. (RID), that journey has taken more than a decade, required nearly $20 million in
From Discovery to Market III: Rapid Infection Diagnostics Inc. Read More »
Genomic tools and technologies have the potential to improve our health, environment and nutrition, and Alberta has no shortage of entrepreneurs ready to meet the challenge. However, while biotech startups are typically well-equipped to test and refine their technologies and products, scaling-up into a sustainable business presents a wholly new challenge. A 2025 survey conducted
Connecting New Business Grads With Genomics Innovators Read More »
From Lab Discovery to Global Impact: How Nova Medical Testing Inc. is Advancing Metabolomics in Alberta and Beyond In the world of life sciences, timing is everything. While genomics can help predict what might happen in the body, metabolomics reveals what has already happened and provides a powerful perspective that is becoming increasingly important
From Discovery to Market II: Nova Medical Testing Inc. Read More »
Lighting the Way: A Calgary Startup Tackles One of Canada’s Biggest Environmental Challenges In northern Alberta, one of the most complex environmental challenges in the world continues to grow quietly but persistently. More than a trillion litres of oil sands tailings water sit across vast landscapes, awaiting a viable path to treatment and eventual
From Discovery to Market I: Luminous BioSolutions Inc. Read More »
Alberta is in the midst of a transformation. Alongside the oil sands and the agricultural industries that have long defined its economy, a new sector is taking shape: a growing life sciences industry that is converting university research into patented technologies, commercialized products, and competitive companies with global reach. The numbers tell a compelling story,
From Discovery to Market: Alberta Life Sciences Companies Creating Real Value Read More »
Federal investment through Genome Canada and the regional Genome Centres helps Canadian companies use genomics and biotech innovation to grow while unlocking private sector co-investment in research and development (R&D). June 23, 2026 Toronto, Ontario – Smarter production is the goal of the HARVEST agri-tech accelerator that’s investing in cleantech and agricultural companies to
$7 Million to Grow Canada’s Agriculture Tech Sector Read More »
Overcoming barriers of integrating genomics research into mental health care In Canada, 1 in 5 people will experience a mental illness in their lifetime. Mental Health Awareness Month takes place every year in May, helping Canadians find greater opportunities to learn and talk openly about mental illnesses without stigma. Improving health outcomes for all
The Biology of Mental Health Read More »
May 8, 2026 Toronto, Ontario – Agriculture and Agri-Food Canada Canadian agri-businesses are leading the way in creating new solutions to reduce emissions and make agriculture more resilient. The Government of Canada is supporting this effort by working with Canadian non-for-profit agtech organizations to help science-focused small- and medium-sized businesses develop innovative technologies that grow
March 31, 2026 Calgary, Alberta – Genome Alberta, with support from the Government of Alberta, is pleased to announce five new projects, with a total value of $2.9 million to accelerate broader application of genomic technologies for improving environmental outcomes in Alberta’s energy sector. Genomics is the big data science that allows us to study
Alberta Biotech to Strengthen Environmental Performance in the Energy Sector Read More »
https://genomealberta.ca/alberta-biotech-to-strengthen-environmental-performance-in-the-energy-sector/
